Avalo Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Nov 24 | BuyUS$12,750 | June Almenoff | Individual | 1,000 | US$13.00 |
Insider Trading Volume
Insider Buying: AVTX insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 58,346 | 0.519% |
Individual Insiders | 550,676 | 4.9% |
Institutions | 1,939,126 | 17.2% |
General Public | 2,275,207 | 20.2% |
Hedge Funds | 2,875,870 | 25.6% |
VC/PE Firms | 3,545,667 | 31.5% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1205.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,905,511 | US$18.0m | 0% | 0.55% | |||
1,611,667 | US$15.2m | 0% | 0.21% | |||
970,359 | US$9.1m | 1,670% | 2.69% | |||
967,000 | US$9.1m | 0% | 0.12% | |||
967,000 | US$9.1m | 757% | 0.29% | |||
549,467 | US$5.2m | 96,600% | no data | |||
539,079 | US$5.1m | 0% | 0.62% | |||
483,000 | US$4.6m | 1,110% | 0.32% | |||
483,000 | US$4.6m | 0% | 0.41% | |||
164,092 | US$1.5m | 1,380% | 0.05% | |||
78,255 | US$737.7k | 0% | 100.0% | |||
71,458 | US$673.6k | 0% | 0.33% | |||
58,346 | US$550.0k | 0% | no data | |||
45,000 | US$424.2k | 0% | 0.08% | |||
42,100 | US$396.8k | 0% | 0.03% | |||
10,368 | US$97.7k | 0% | no data | |||
10,111 | US$95.3k | 1,720% | no data | |||
6,134 | US$57.8k | 71.2% | no data | |||
5,601 | US$52.8k | 0% | no data | |||
1,000 | US$9.4k | 0% | no data | |||
376 | US$3.5k | 0% | no data | |||
329 | US$3.1k | 0% | no data | |||
191 | US$1.8k | 0% | no data | |||
143 | US$1.3k | 0% | no data | |||
60 | US$561.8 | 0% | no data |